These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30062623)

  • 41. CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation.
    Glotzer TV; Hellkamp AS; Lee KL; Lamas GA
    Can J Cardiol; 2015 Aug; 31(8):1004-11. PubMed ID: 26076964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2-VASc Score of 1 (Men) or 2 (Women)?
    Hung Y; Chao TF; Liu CJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Liao JN; Chung FP; Lin WY; Lin WS; Cheng SM; Chen TJ; Lip GY; Chen SA
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27702803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure.
    Hamatani Y; Iguchi M; Nakamura M; Ohtani R; Yamashita Y; Takagi D; Unoki T; Ishii M; Masunaga N; Ogawa H; Hamatani M; Abe M; Akao M
    Heart Vessels; 2016 Jul; 31(7):1154-61. PubMed ID: 26219729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High prevalence of atrial fibrillation among patients with ischemic stroke.
    Friberg L; Rosenqvist M; Lindgren A; Terént A; Norrving B; Asplund K
    Stroke; 2014 Sep; 45(9):2599-605. PubMed ID: 25034713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atrial fibrillation and cardioembolic stroke.
    Ferro JM
    Minerva Cardioangiol; 2004 Apr; 52(2):111-24. PubMed ID: 15194993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-Term Risk of Ischemic Stroke After the Cox-Maze III Procedure for Atrial Fibrillation.
    Albåge A; Sartipy U; Kennebäck G; Johansson B; Scherstén H; Jidéus L;
    Ann Thorac Surg; 2017 Aug; 104(2):523-529. PubMed ID: 28242081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel composite scoring system to predict unknown atrial fibrillation in acute ischemic stroke patients.
    Liu R; Yang X; Li S; Jiang Y; Wang Y; Wang Y
    Brain Res; 2017 Nov; 1674():36-41. PubMed ID: 28823956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.
    Xiong Q; Lau YC; Senoo K; Lane DA; Hong K; Lip GY
    Eur J Heart Fail; 2015 Nov; 17(11):1192-200. PubMed ID: 26335355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atrial fibrillation patients categorized as "not for anticoagulation" according to the 2014 Canadian Cardiovascular Society algorithm are not "low risk".
    Lip GY; Nielsen PB; Skjøth F; Rasmussen LH; Larsen TB
    Can J Cardiol; 2015 Jan; 31(1):24-8. PubMed ID: 25547546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
    Fauchier L; Clementy N; Bisson A; Ivanes F; Angoulvant D; Babuty D; Lip GY
    Stroke; 2016 Jul; 47(7):1831-6. PubMed ID: 27231269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
    Senoo K; Lane DA; Lip GY
    Int J Cardiol; 2015 Feb; 181():247-54. PubMed ID: 25528530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
    Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
    J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heart Failure and Mortality in Patients With Nonvalvular Atrial Fibrillation Started on Novel Oral Anticoagulant Therapy: A Single-Center Experience.
    Sunbul M; Oguz M; Dogan Z; Atas H; Bozbay M; Cincin A; Agirbasli M
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):454-459. PubMed ID: 26566667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.
    Ferreira JP; Girerd N; Alshalash S; Konstam MA; Zannad F
    Eur Heart J; 2016 Aug; 37(31):2455-64. PubMed ID: 27252452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of Ischemic Stroke in Patients With Non-Valvular Atrial Fibrillation Not Receiving Oral Anticoagulants　- Korean Nationwide Population-Based Study.
    Kang SH; Choi EK; Han KD; Lee SR; Lim WH; Cha MJ; Cho Y; Oh IY; Oh S
    Circ J; 2017 Jul; 81(8):1158-1164. PubMed ID: 28413184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.